← Open Payments lookup

HANNAH SMITH: Open Payments

NPI 1093227688 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$876 in 39 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $102 · 2025 $876

Food & beverage: $876
CompanyPaymentsAmount
Ipsen Biopharmaceuticals, Inc5$169
ABBVIE INC.9$141
Madrigal Pharmaceuticals3$102
Celltrion USA Inc.4$98
Janssen Biotech, Inc.4$93
Regeneron Healthcare Solutions, Inc.2$68
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$58
Aimmune Therapeutics, Inc.2$43
Takeda Pharmaceuticals U.S.A., Inc.2$35
Phathom Pharmaceuticals, Inc.3$26

Products named: IQIRVO, REZDIFFRA, VEGZELMA, DUPIXENT, TREMFYA, RINVOQ, XIFAXAN, CREON.

Industry payments across AR — which companies pay providers there.